These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16805236)

  • 1. Prenatal panel screening considerations for non-neuronopathic Gaucher disease in the Ashkenazi-Jewish population.
    Kannai R; Chertok IR
    Isr Med Assoc J; 2006 May; 8(5):347-50. PubMed ID: 16805236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes of couples identified through screening as carriers of Gaucher disease type 1.
    Zuckerman S; Lahad A; Zimran A; Levy-Lahad E; Sagi M
    Clin Genet; 2008 Dec; 74(6):566-70. PubMed ID: 18651845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus.
    Reissner K; Tayebi N; Stubblefield BK; Koprivica V; Blitzer M; Holleran W; Cowan T; Almashanu S; Maddalena A; Karson EM; Sidransky E
    Mol Genet Metab; 1998 Apr; 63(4):281-8. PubMed ID: 9635296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases.
    Zuckerman S; Lahad A; Shmueli A; Zimran A; Peleg L; Orr-Urtreger A; Levy-Lahad E; Sagi M
    JAMA; 2007 Sep; 298(11):1281-90. PubMed ID: 17878420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sixteen years of prenatal consultations for the N370S/N370S Gaucher disease genotype: what have we learned?
    Eitan Y; Abrahamov A; Phillips M; Elstein D; Zimran A
    Prenat Diagn; 2010 Oct; 30(10):924-7. PubMed ID: 20721872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier screening for Gaucher disease in couples of mixed ethnicity.
    Wallerstein R; Starkman A; Jansen V
    Genet Test; 2001; 5(1):61-4. PubMed ID: 11336404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quest for the perfect baby: why do Israeli women seek prenatal genetic testing?
    Remennick L
    Sociol Health Illn; 2006 Jan; 28(1):21-53. PubMed ID: 16509941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gaucher disease: clinical, genetic and therapeutic aspects].
    Germain DP
    Pathol Biol (Paris); 2004 Jul; 52(6):343-50. PubMed ID: 15261378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frequency of the Gaucher mutation among recent Russian immigrants].
    Hodish I; Elstein D; Abrahamov A; Lonshakova N; Zimran A
    Harefuah; 1995 Jun; 128(12):757-8, 824. PubMed ID: 7557682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Look before you leap. Carrier screening for type 1 Gaucher disease: difficult questions.
    Borry P; Clarke A; Dierickx K
    Eur J Hum Genet; 2008 Feb; 16(2):139-40. PubMed ID: 18043719
    [No Abstract]   [Full Text] [Related]  

  • 13. Polymorphisms in glucosylceramide (glucocerebroside) synthase and the Gaucher disease phenotype.
    Beutler E; West C
    Isr Med Assoc J; 2002 Nov; 4(11):986-8. PubMed ID: 12489486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased incidence of Parkinson disease among relatives of patients with Gaucher disease.
    Halperin A; Elstein D; Zimran A
    Blood Cells Mol Dis; 2006; 36(3):426-8. PubMed ID: 16651014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued?
    Zlotogora J; Leventhal A
    Isr Med Assoc J; 2000 Sep; 2(9):665-7. PubMed ID: 11062764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze.
    Ferreira JC; Schreiber-Agus N; Carter SM; Klugman S; Gregg AR; Gross SJ
    Am J Obstet Gynecol; 2014 Sep; 211(3):197-204. PubMed ID: 24508465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest of the world.
    Sobreira E; Pires RF; Cizmarik M; Grabowski GA
    Mol Genet Metab; 2007 Jan; 90(1):81-6. PubMed ID: 16996765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gaucher disease in Arab patients at an Israeli referral clinic.
    Brautbar A; Abrahamov A; Hadas-Halpern I; Elstein D; Zimran A
    Isr Med Assoc J; 2008; 10(8-9):600-2. PubMed ID: 18847161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic Gaucher disease implications for large-scale screening.
    Azuri J; Elstein D; Lahad A; Abrahamov A; Hadas-Halpern I; Zimran A
    Genet Test; 1998; 2(4):297-9. PubMed ID: 10464607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews.
    Zimran A; Gelbart T; Westwood B; Grabowski GA; Beutler E
    Am J Hum Genet; 1991 Oct; 49(4):855-9. PubMed ID: 1897529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.